Can Fite Biopharma Ltd
CANF4.160USD
+0.100+2.35%
終値 02/06, 16:00（ET）15分遅れの株価
5.50M時価総額
損失額直近12ヶ月PER
詳細情報 Can Fite Biopharma Ltd 企業名
Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
Can Fite Biopharma Ltdの企業情報
企業コードCANF
会社名Can Fite Biopharma Ltd
上場日Sep 22, 2005
最高経営責任者「CEO」Fishman (Pnina)
従業員数5
証券種類Depository Receipt
決算期末Sep 22
本社所在地10 Bareket Street, Kiryat Matalon
都市PETAH TIKVA
証券取引所NASDAQ OMX – NASDAQ Basic Amex
国Israel
郵便番号49170
電話番号97239241114
ウェブサイトhttps://www.canfite.com/
企業コードCANF
上場日Sep 22, 2005
最高経営責任者「CEO」Fishman (Pnina)
Can Fite Biopharma Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. Abraham Sartani, M.D.
Dr. Abraham Sartani, M.D.
Independent Director
Independent Director
--
--
Mr. Guy Regev
Mr. Guy Regev
Independent Director
Independent Director
--
--
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Yoseph Borenstein
Mr. Yoseph Borenstein
Director
Director
--
--
Mr. Yaacov Goldman
Mr. Yaacov Goldman
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. Abraham Sartani, M.D.
Dr. Abraham Sartani, M.D.
Independent Director
Independent Director
--
--
Mr. Guy Regev
Mr. Guy Regev
Independent Director
Independent Director
--
--
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
収益内訳
会社から関連データがまだ開示されていません。
会社から関連データがまだ開示されていません。
事業別
地域別
会社から関連データがまだ開示されていません。
株主
更新時刻: Tue, Jan 6
更新時刻: Tue, Jan 6
株主統計
種類
株主統計
株主統計
比率
Sabby Management, LLC
5.37%
Rhumbline Advisers Ltd. Partnership
0.22%
Abalone Asset Management Ltd.
0.09%
UBS Financial Services, Inc.
0.08%
BNP Paribas Securities Corp. North America
0.06%
他の
94.17%
株主統計
株主統計
比率
Sabby Management, LLC
5.37%
Rhumbline Advisers Ltd. Partnership
0.22%
Abalone Asset Management Ltd.
0.09%
UBS Financial Services, Inc.
0.08%
BNP Paribas Securities Corp. North America
0.06%
他の
94.17%
種類
株主統計
比率
Investment Advisor/Hedge Fund
5.37%
Investment Advisor
0.51%
Research Firm
0.12%
Hedge Fund
0.04%
他の
93.96%
機関投資家保有株
更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
30
1.56M
6.39%
--
2025Q3
33
1.56M
9.88%
+633.60K
2025Q2
31
928.79K
6.69%
+773.65K
2025Q1
30
155.14K
8.36%
-710.63K
2024Q4
28
138.24K
8.71%
-639.91K
2024Q3
26
778.14K
10.55%
+126.51K
2024Q2
26
651.74K
10.05%
+134.05K
2024Q1
24
517.69K
5.29%
+253.94K
2023Q4
29
283.94K
2.08%
+216.17K
2023Q3
28
67.77K
12.19%
+13.03K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Sabby Management, LLC
70.30K
5.37%
+31.32K
+80.32%
Sep 30, 2025
Rhumbline Advisers Ltd. Partnership
2.90K
0.22%
+18.00
+0.63%
Sep 30, 2025
Abalone Asset Management Ltd.
1.19K
0.09%
-809.00
-40.45%
Jun 30, 2024
UBS Financial Services, Inc.
65.00
0.01%
-211.00
-76.45%
Sep 30, 2025
BNP Paribas Securities Corp. North America
829.00
0.06%
-50.00
-5.69%
Sep 30, 2025
Bogart Wealth, LLC
752.00
0.06%
+752.00
--
Sep 30, 2025
Morgan Stanley & Co. LLC
626.00
0.05%
+130.00
+26.21%
Sep 30, 2025
CAPTRUST Financial Advisors
569.00
0.04%
--
--
Sep 30, 2025
Two Sigma Investments, LP
532.00
0.04%
-271.00
-33.75%
Sep 30, 2025
MainStreet Advisors
150.00
0.01%
--
--
Sep 30, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
Dec 23, 2025
Merger
20→1
Dec 23, 2025
Merger
20→1
Jan 03, 2023
Merger
10→1
Jan 03, 2023
Merger
10→1
Jan 03, 2023
Merger
10→1
Jan 03, 2023
Merger
10→1
日付
配当落ち日
種類
比率
Dec 23, 2025
Merger
20→1
Dec 23, 2025
Merger
20→1
Jan 03, 2023
Merger
10→1
Jan 03, 2023
Merger
10→1
Jan 03, 2023
Merger
10→1
Jan 03, 2023
Merger
10→1
